DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine trials
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine trials
newKerala.com
0 shares
1 views
You might like
Related news coverage
A Global Race And Safety Fears, After Russia Approves COVID-19 Vaccine
Newsy
Watch VideoHealth and security experts are questioning the validity of the world’s first registered COVID-19 vaccine — after..
-
Phase 2 trial of Oxford COVID-19 vaccine candidate to begin today
Mid-Day
-
Will the superfast 'Sputnik V' vaccine put citizens at risk?
Mid-Day
-
Serum gets DCGI nod for Phase 2 & 3 trials
IndiaTimes
-
DCGI allows Serum Institute to conduct phase II+III trials of Oxford University vaccine COVISHIELD for COVID-19
Zee News
Advertisement
More coverage
DCGI allows Serum Institute to conduct phase II+III trials of coronavirus vaccine COVISHIELD
Zee News
According to the Indian Council of Medical Research, the COVID-19 tests around India crossed a two-crore mark on Monday.
-
DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccine
IndiaTimes
-
Coronavirus | DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate
Hindu
-
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in India
newKerala.com
-
Serum Institute gets DCGI nod for clinical trials of Oxford vax
Mid-Day